Abstract
High selectivity (82 %) to 3-methyl-6-(prop-1-en-2-yl)cyclohex-3-ene- 1,2-diol, a potent anti-Parkinson drug, was achieved in the isomerization of verbenol oxide at the conversion level of 96 % in N,N-dimethylacetamide at 140 °C over a metal modified zeolite, Fe-Beta-300 with SiO2 to Al2O3 ratio of 300. This catalyst exhibits both weak and medium strong Brønsted and Lewis acid sites.
Original language | English |
---|---|
Pages (from-to) | 449-458 |
Number of pages | 10 |
Journal | Reaction Kinetics, Mechanisms and Catalysis |
Volume | 110 |
Issue number | 2 |
DOIs | |
Publication status | Published - Aug 2013 |
MoE publication type | A1 Journal article-refereed |
Keywords
- Isomerization
- Mesoporous material
- Verbenol oxide
- Zeolite